Here’s Where Chemicals Companies Are Investing As The Industry Consolidates
Chemicals companies are investing in new technologies and completing small M&A deals, mainly in analytics, biotech, agriculture, and healthcare.
Chemicals companies are investing in new technologies and completing small M&A deals, mainly in analytics, biotech, agriculture, and healthcare.
A new generation of cancer immunotherapies are emerging and attracting high-dollar investments from leading venture and corporate players. Here we explore 19 private cancer startups working on therapies that go beyond the traditional treatments, from personalized vaccines to immune-stimulating gut microbes.
Mother Nature does it first. Tech follows behind.
The head of computing at Google's anti-aging research firm envisions data as a key tool to expand personalized medicine — and maybe eventually extend human life.
While deal flow remains even, a $1B+ raise by Roivant Sciences is boosting funding in the European pharma sector to record highs.
Study participants are swallowing pills containing gene-modified E. coli bacteria designed to absorb excess ammonia in the body.
Healthcare is changing around the world. The very definition of medicine is now up for debate. Across digital health, biotechnology, and the medical device sector, startups are finally bringing medicine into the 21st century. In this report we take a look at cutting edge developments in healthcare, and the startups behind them that are just beginning to impact the world.
Scientists screened a library of 100 million antibodies to find several that offer an easier way to reprogram adult cells into stem cells.
This dime-sized chip transforms cells from one type to another with a small electrical pulse – creating a non-invasive, instantaneous way to repair injured tissue.
Exposure to indole compounds produced by E coli bacteria helped certain animals stay active and mobile at advanced ages – paving the way for new drugs that could help humans live well into old age.